Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Regulatory Workaround, Not Statutory Changes, Better For Personalized Medicine Development, FDA Commissioner Hamburg Says

Mar 08 2010

• By The Pink Sheet

Related Content

Nephrotoxicity Biomarkers To Be Test Run For FDA Qualification Program

Jul 09 2007

Biomarker Qualification Guidance To Require Fit For Use Validation

Mar 27 2006

FDA Genomics Guidance, Demographics Database To Improve Gender Analysis

Nov 03 2003

FDA Diagnostics Office Seeks Bigger Role In Personalized Medicine

Apr 27 2009

Regulatory Science: FDA Gets Help From NIH, But Is It Enough?

Mar 01 2010

Dx Groups To FDA: Time For Companion Diagnostics Guidance Is Now

Jan 11 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window